J84 Other interstitial pulmonary diseases

⚠ Non-Billable ICD-10-CM 2026
Open J84 in Web App →

The ICD-10-CM code for Other interstitial pulmonary diseases is J84 (FY2026). It is a non-billable category code — select a more specific code below for claims.

Classification

Section
J80-J84: Other respiratory diseases principally affecting the interstitium (J80-J84)
Category J84
31 codes (24 billable)
FY2026 Status
Stable since FY2024
Excludes1
Not coded here. These conditions should NOT be coded together with J84.
  • drug-induced interstitial lung disorders (J70.2-J70.4)
  • interstitial emphysema (J98.2)
Excludes2
Not included here. These conditions are coded elsewhere but may be coded together if applicable.
  • lung diseases due to external agents (J60-J70)
Code Also
  • , if applicable, associated condition

Official Coding Guidelines

COPD/asthma: acute exacerbation vs uncomplicated

a. Chronic Obstructive Pulmonary Disease [COPD] and Asthma 1) Acute exacerbation of chronic obstructive bronchitis and asthma The codes in categories J44 and J45 distinguish between uncomplicated cases and those in acute exacerbation. An acute exacerbation is a worsening or a decompensation of a chronic condition. An acute exacerbation is not equivalent to an infection superimposed on a chronic condition, though an exacerbation may be triggered by an infection.

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.10.a.1
Acute respiratory failure as principal diagnosis

b. Acute Respiratory Failure 1) Acute respiratory failure as principal diagnosis A code from subcategory J96.0, Acute respiratory failure, or subcategory J96.2, Acute and chronic respiratory failure, may be assigned as a principal diagnosis when it is the condition established after study to be chiefly responsible for occasioning the admission to the hospital, and the selection is supported by the Alphabetic Index and Tabular List. However, chapter- specific coding guidelines (such as obstetrics, poisoning, HIV, newborn) that provide sequencing direction take precedence.

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.10.b.1

Source: CMS — ICD-10-CM Official Guidelines for Coding and Reporting, FY2026

References

Related Codes

More Specific Codes

J84.0 Alveolar and parieto-alveolar conditions J84.01 Alveolar proteinosis J84.02 Pulmonary alveolar microlithiasis J84.03 Idiopathic pulmonary hemosiderosis J84.09 Other alveolar and parieto-alveolar conditions J84.1 Other interstitial pulmonary diseases with fibrosis J84.10 Pulmonary fibrosis, unspecified J84.11 Idiopathic interstitial pneumonia J84.111 Idiopathic interstitial pneumonia, not otherwise specified J84.112 Idiopathic pulmonary fibrosis J84.113 Idiopathic non-specific interstitial pneumonitis J84.114 Acute interstitial pneumonitis J84.115 Respiratory bronchiolitis interstitial lung disease J84.116 Cryptogenic organizing pneumonia J84.117 Desquamative interstitial pneumonia J84.17 Other interstitial pulmonary diseases with fibrosis in diseases classified elsewhere J84.170 Interstitial lung disease with progressive fibrotic phenotype in diseases classified elsewhere J84.178 Other interstitial pulmonary diseases with fibrosis in diseases classified elsewhere J84.2 Lymphoid interstitial pneumonia J84.8 Other specified interstitial pulmonary diseases J84.81 Lymphangioleiomyomatosis J84.82 Adult pulmonary Langerhans cell histiocytosis J84.83 Surfactant mutations of the lung J84.84 Other interstitial lung diseases of childhood J84.841 Neuroendocrine cell hyperplasia of infancy J84.842 Pulmonary interstitial glycogenosis J84.843 Alveolar capillary dysplasia with vein misalignment J84.848 Other interstitial lung diseases of childhood J84.89 Other specified interstitial pulmonary diseases J84.9 Interstitial pulmonary disease, unspecified

Related Codes in J84

Search all 70,000+ ICD-10-CM codes →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2025-10-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial